Dare Bioscience
DARE
27 hedge funds and large institutions have $5.13M invested in Dare Bioscience in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
37% more capital invested
Capital invested by funds: $3.73M → $5.13M (+$1.4M)
0.02% more ownership
Funds ownership: 0.16% → 0.18% (+0.02%)
10% less funds holding
Funds holding: 30 → 27 (-3)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $53K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$911K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$478K |
| 3 |
State Street
Boston,
Massachusetts
|
+$107K |
| 4 |
BlackRock
New York
|
+$71K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DVC
Deer VII & Co
Larchmont,
New York
|
-$118K |
| 2 |
Renaissance Technologies
New York
|
-$38K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$29K |
| 4 |
Morgan Stanley
New York
|
-$27.9K |
| 5 |
Goldman Sachs
New York
|
-$24K |
DARE Hedge Fund Activity: Q1 2017 in Review
27 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2017, worth a combined $5.13M — up 37% from $3.73M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of DARE and 7 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 8 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $911K. The largest seller was Deer VII & Co, exiting entirely with an estimated $118K sold.
- 27 institutional investors held Dare Bioscience (DARE) as of Q1 2017, down from 30 in Q4 2016.
- Funds reported $5.13M of Dare Bioscience stock for Q1 2017, up 37% quarter-over-quarter.
- 7 funds opened new Dare Bioscience positions in Q1 2017 and 8 closed out, a net change of -1 holder.
- The largest Dare Bioscience buyer in Q1 2017 was Virtu KCG Holdings, an estimated $911K added.
- The largest Dare Bioscience seller in Q1 2017 was Deer VII & Co, an estimated $118K sold.
Based on aggregated 13F filings for Q1 2017.